Scribd Logo
Upload

Welcome to Scribd!

  • 33 views

    CBC, S Creatnine, Malaria

    Uploaded by

    Chitransh Saxena
    - The patient, Shivi Saxena, had a high sensitivity C-reactive protein (hs-CRP) level of 22.15 mg/L, indicating high risk of cardiovascular disease. Tests for typhoid IgG and IgM, and plasmodium falciparum and vivax were all negative. - A complete blood count showed mild anemia with elevated red cell distribution width and mild anisopoikilocytosis, predominantly normocytic normochromic cells with ovalocytes. The white blood cell count and differential were normal. - These results indicate possible non-cardiac inflammation as the cause of elevated hs-CRP and mild anemia. Further clinical correlation is needed.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    CBC, S Creatnine, Malaria

    Uploaded by

    Chitransh Saxena
    33 views5 pages
    - The patient, Shivi Saxena, had a high sensitivity C-reactive protein (hs-CRP) level of 22.15 mg/L, indicating high risk of cardiovascular disease. Tests for typhoid IgG and IgM, and plasmodium falciparum and vivax were all negative. - A complete blood count showed mild anemia with elevated red cell distribution width and mild anisopoikilocytosis, predominantly normocytic normochromic cells with ovalocytes. The white blood cell count and differential were normal. - These results indicate possible non-cardiac inflammation as the cause of elevated hs-CRP and mild anemia. Further clinical correlation is needed.

    Original Description:

    Cbc jbbj j kvkcif j uvu j j kbk j j j j

    Original Title

    CBC, s creatnine, malaria

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    - The patient, Shivi Saxena, had a high sensitivity C-reactive protein (hs-CRP) level of 22.15 mg/L, indicating high risk of cardiovascular disease. Tests for typhoid IgG and IgM, and plasmodium falciparum and vivax were all negative. - A complete blood count showed mild anemia with elevated red cell distribution width and mild anisopoikilocytosis, predominantly normocytic normochromic cells with ovalocytes. The white blood cell count and differential were normal. - These results indicate possible non-cardiac inflammation as the cause of elevated hs-CRP and mild anemia. Further clinical correlation is needed.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    33 views5 pages

    CBC, S Creatnine, Malaria

    Uploaded by

    Chitransh Saxena
    - The patient, Shivi Saxena, had a high sensitivity C-reactive protein (hs-CRP) level of 22.15 mg/L, indicating high risk of cardiovascular disease. Tests for typhoid IgG and IgM, and plasmodium falciparum and vivax were all negative. - A complete blood count showed mild anemia with elevated red cell distribution width and mild anisopoikilocytosis, predominantly normocytic normochromic cells with ovalocytes. The white blood cell count and differential were normal. - These results indicate possible non-cardiac inflammation as the cause of elevated hs-CRP and mild anemia. Further clinical correlation is needed.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 5

    PROCESSED AT :

    Thyrocare
    D-79, 3rd floor, sector-63,
    gautam budh nagar,
    Noida, UP-201301.

    NAME : SHIVI SAXENA(26Y/F) HOME COLLECTION :


    REF. BY : SELF 436-437 BLOCK B GD COLONY BLOCK B MAYUR
    VIHAR PHASE III DELHI 110096 INDIA
    TEST ASKED : FEVER PROFILE,HEMOGRAM,hsCRP

    PATIENTID : SS20280289
    TEST NAME TECHNOLOGY VALUE UNITS
    HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 22.15 mg/L
    Reference Range :-

    < 1.00 - Low Risk


    1.00 - 3.00 - Average Risk
    >3.00 - 10.00 - High Risk
    > 10.00 - Possibly due to Non-Cardiac Inflammation

    Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as infection ,
    active arthritis or concurrent illness.

    Clinical significance:
    High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk for
    future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP tests, ideally
    taken two weeks apart.

    Kit Validation Reference:


    1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
    2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

    Please correlate with clinical conditions.


    Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

    Sample Collected on (SCT) : 05 Jul 2023 09:28


    Sample Received on (SRT) : 05 Jul 2023 12:23
    Report Released on (RRT) : 06 Jul 2023 03:11
    Sample Type : SERUM
    Dr Neha Prabhakar MD(Path)
    Labcode : 0507040340/PP004
    Barcode : BC519803 Page : 1 of 5
    PROCESSED AT :
    Thyrocare
    D-79, 3rd floor, sector-63,
    gautam budh nagar,
    Noida, UP-201301.

    NAME : SHIVI SAXENA(26Y/F) HOME COLLECTION :


    REF. BY 436-437 BLOCK B GD COLONY BLOCK B MAYUR
    : SELF
    VIHAR PHASE III DELHI 110096 INDIA
    TEST ASKED : FEVER PROFILE,HEMOGRAM,hsCRP

    PATIENTID : SS20280289
    TEST NAME TECHNOLOGY RESULT

    TYPHOID-IGG IMMUNOASSAY NEGATIVE

    Method : LATERAL FLOW IMMUNOASSAY


    TYPHOID-IGM IMMUNOASSAY NEGATIVE

    Method : LATERAL FLOW IMMUNOASSAY


    Please correlate with clinical conditions.

    Note : This is a screening test and a positive report does not confirm diagnosis. All positive cases should be verified by
    confirmatory methods

    Sample Collected on (SCT) : 05 Jul 2023 09:28

    Sample Received on (SRT) : 05 Jul 2023 12:23


    Report Released on (RRT) : 06 Jul 2023 03:11
    Sample Type : SERUM
    Labcode : 0507040340/PP004 Dr Neha Prabhakar MD(Path)
    Barcode : BC519803
    Page : 2 of 5
    PROCESSED AT :
    Thyrocare
    D-79, 3rd floor, sector-63,
    gautam budh nagar,
    Noida, UP-201301.

    NAME : SHIVI SAXENA(26Y/F) HOME COLLECTION :


    REF. BY 436-437 BLOCK B GD COLONY BLOCK B MAYUR
    : SELF
    VIHAR PHASE III DELHI 110096 INDIA
    TEST ASKED : FEVER PROFILE,HEMOGRAM,hsCRP

    PATIENTID : SS20280289
    TEST NAME TECHNOLOGY RESULT

    PLASMODIUM FALCIPARUM IMMUNOASSAY NEGATIVE

    Method : RAPID IMMUNOASSAY


    PLASMODIUM VIVAX IMMUNOASSAY NEGATIVE

    Method : RAPID IMMUNOASSAY


    Please correlate with clinical conditions.

    METHODOLOGY : RAPID CARD BASED ON THE PRINCIPLE OF IMMUNOCHROMATOGRAPHY

    CLINICAL SIGNIFICANCE : Malaria is caused by four species of Plasmodium:- P. falciparum, P. Vivax, P. ovale & P.malariae.
    The disease results from the multiplication of malaria parasites within red blood cells of the host causing symptoms that typically
    include fever, headache, joint pain, vomiting, anemia, hemoglobinuria, retinal damage, convulsions, in severe cases progressing
    to coma and death. Rapid Test can be used as an aid in detection of specific antigen to Plasmodium vivax (Pv) PLDH and
    Plasmodium falciparum (Pf) HRP-2 in human whole blood.

    SPECIFICATIONS : Sensitivity: For PfHRP-II: 98.5% & For PvLDH: 100% Specificity: For PfHRP-II: 99% & For PvLDH: 99%

    KIT VALIDATION REFERENCE : Makler, M. et al (1993) Parasite lactate assay for Plasmodium falciparum drug sensitivity AmJ .
    Trop. Med. Hyg. 48(6), 739-741

    Please correlate with clinical conditions.

    Note : This is a screening test and a positive report does not confirm diagnosis. All positive cases should be verified by
    confirmatory methods

    Sample Collected on (SCT) : 05 Jul 2023 09:28

    Sample Received on (SRT) : 05 Jul 2023 12:30


    Report Released on (RRT) : 05 Jul 2023 13:45
    Sample Type : EDTA
    Labcode : 0507040360/PP004 Dr Neha Prabhakar MD(Path)
    Barcode : BC798093
    Page : 3 of 5
    PROCESSED AT :
    Thyrocare
    D-79, 3rd floor, sector-63,
    gautam budh nagar,
    Noida, UP-201301.

    NAME : SHIVI SAXENA(26Y/F) HOME COLLECTION :


    REF. BY : SELF 436-437 BLOCK B GD COLONY BLOCK B MAYUR
    VIHAR PHASE III DELHI 110096 INDIA
    TEST ASKED : FEVER PROFILE,HEMOGRAM,hsCRP
    PATIENTID : SS20280289
    TEST NAME VALUE UNITS REFERENCE RANGE
    TOTAL LEUCOCYTES COUNT (WBC) 7.75 X 10³ / µL 4.0 - 10.0
    NEUTROPHILS 75.7 % 40-80
    LYMPHOCYTE 15.7 % 20-40
    MONOCYTES 3.6 % 2-10
    EOSINOPHILS 4.3 % 1-6
    BASOPHILS 0.4 % 0-2
    IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4
    NEUTROPHILS - ABSOLUTE COUNT 5.74 X 10³ / µL 2.0-7.0
    LYMPHOCYTES - ABSOLUTE COUNT 1.22 X 10³ / µL 1.0-3.0
    MONOCYTES - ABSOLUTE COUNT 0.28 X 10³ / µL 0.2 - 1.0
    BASOPHILS - ABSOLUTE COUNT 0.03 X 10³ / µL 0.02 - 0.1
    EOSINOPHILS - ABSOLUTE COUNT 0.33 X 10³ / µL 0.02 - 0.5
    IMMATURE GRANULOCYTES(IG) 0.15 X 10³ / µL 0.0-0.3
    TOTAL RBC 4.28 X 10^6/µL 3.8-4.8
    NUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL 0.0-0.5
    NUCLEATED RED BLOOD CELLS % 0.01 % 0.0-5.0
    HEMOGLOBIN 11.6 g/dL 12.0-15.0
    HEMATOCRIT(PCV) 34.9 % 36.0-46.0
    MEAN CORPUSCULAR VOLUME(MCV) 81.5 fL 83.0-101.0
    MEAN CORPUSCULAR HEMOGLOBIN(MCH) 27.1 pq 27.0-32.0
    MEAN CORP.HEMO.CONC(MCHC) 33.2 g/dL 31.5-34.5
    RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 49.5 fL 39.0-46.0
    RED CELL DISTRIBUTION WIDTH (RDW-CV) 16.8 % 11.6-14.0
    PLATELET COUNT 150 X 10³ / µL 150-410
    Remarks : Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

    Please Correlate with clinical conditions.


    Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
    (This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method
    (using a semiconductor laser), and SLS- hemoglobin method)

    ~~ End of report ~~

    Sample Collected on (SCT) : 05 Jul 2023 09:28


    Sample Received on (SRT) : 05 Jul 2023 12:30
    Report Released on (RRT) : 05 Jul 2023 13:45
    Sample Type : EDTA
    Labcode : 0507040360/PP004 Dr Neha Prabhakar MD(Path)
    Barcode : BC798093 Page : 4 of 5
    CONDITIONS OF REPORTING

    v The reported results are for information and interpretation of the referring doctor only.
    v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
    v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
    same patient.
    v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
    v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
    should interpret results.
    v This report is not valid for medico-legal purpose.
    v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
    that may be incurred by any person as a result of presuming the meaning or contents of the report.
    v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
    v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00

    EXPLANATIONS

    v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
    as "Clients".
    v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
    v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
    v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
    v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
    the barcode (irrespective of the name).
    v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
    the client.
    v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
    v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
    v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
    v Reference Range - Means the range of values in which 95% of the normal population would fall.

    SUGGESTIONS

    v Values out of reference range requires reconfirmation before starting any medical treatment.
    v Retesting is needed if you suspect any quality shortcomings.
    v Testing or retesting should be done in accredited laboratories.
    v For suggestions, complaints or feedback, write to us at [email protected] or call us on
    022-3090 0000 / 6712 3400
    v SMS:<Labcode No.> to 9870666333

    Page : 5 of 5

    You might also like